Skip to content

Abstract 9170: Hypertensive Cardiorenal Mortality Co-Occurring With Heart Failure and End-Stage Renal Disease: A 25-Year National Trends Analysis

Nov 2026 · Circulation · 0 citations

Abstract

Introduction: Hypertension is the leading modifiable risk factor for cardiorenal spectrum, with progression to concurrent heart failure (HF) and end-stage renal disease (ESRD) representing a high-risk phenotype. We used a national database to evaluate temporal trends in hypertensive heart and renal disease mortality among adults in the U.S. presenting with co-occurring HF and ESRD. Methods: A retrospective population-based analysis was performed using CDC WONDER (1999-2024). Deaths among adults aged ≥45 years listing hypertensive heart and renal disease with both HF and ESRD (I13.2) as the underlying cause of death were included. Age-adjusted mortality rates (AAMRs) per 1,000,000 were calculated using the 2000 U.S. standard population. Joinpoint regression estimated annual (APC) and average annual percent changes (AAPC). Results: From 1999-2024, 90,570 deaths were identified (mean AAMR: 26.7). Mortality declined until 2010, followed by a significant increase thereafter (AAPC: +5.1; 95% CI: 3.6-6.7; p < 0.001). Increasing trends were observed in both sexes, with slightly higher AAMR in males (28.7 vs 25.3) and steeper post-2014 increases in both groups. The highest burden was observed in adults aged ≥85 years (48,379 deaths). Noncore (nonmetropolitan) areas demonstrated the highest mortality (AAMR: 27.6). All racial groups showed a post-2014 upward inflection, most pronounced among Black or African American individuals (AAMR: 50.1). Regionally, the highest mortality was observed in the South (AAMR: 29.7) and West (AAMR: 29.3). State-level AAMRs ranged from 9.5 (Connecticut) to 307.2 (Oklahoma). Conclusion: The disproportionately higher mortality among older adults, Black individuals, rural populations, and residents of the South highlights persistent inequities in outcomes. The rising mortality trends identify high-risk populations where targeted interventions may yield meaningful improvements in the mortality.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.